Julian Peto MA DSc FMedSci

Professor of Epidemiology

• Affiliation
• Teaching
• Research
• Publications

• 
• Room 256b
• LSHTM
• Keppel Street
• London
• WC1E 7HT
• T: +44 (0)20 7927 2632
• F: +44 (0)20 7436 4230

Julian Peto attended Balliol College, Oxford (MA Maths) and Imperial College, London (MSc Statistics). From 1969 to 1974 he worked as a medical statistician at Edinburgh University, the Institute of Psychiatry and the Medical Research Council's T.B. Unit. He joined Sir Richard Doll's ICRF Cancer Epidemiology and Clinical Trials Unit in Oxford in 1974, and was appointed Chairman of the Section of Epidemiology at the Institute of Cancer Research in 1983. He joined the London School of Hygiene & Tropical Medicine in 1998. His Chair of Epidemiology, now at the London School of Hygiene & Tropical Medicine, is supported by Cancer Research UK.

His main current research interests are asbestos-related cancers, the role of HPV testing in cervical cancer screening, and breast cancer genetics. He leads the VIDAL (Vitamin D and longevity) trial of high-dose vitamin D in healthy adults aged over 65 which will be launched in 2011.

Affiliation

• Department of Non-communicable Disease Epidemiology

Teaching

He is a tutor for the MSc in Epidemiology and supervises PhD students.

Research

Professor Peto and his colleagues carry out epidemiological studies and genetic research on various cancers. His work has included studies on asbestos and other occupational carcinogens, childhood cancers, oral contraceptives and breast cancer, the natural history of human papillomavirus (HPV) infection and cervical cancer, particularly in relation to screening, and the genetics of breast cancer. He has also been involved in many randomised studies of cancer treatment.

• Selected publications

• Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility.

  Johnson, N.; Fletcher, O.; Palles, C.; Rudd, M.; Webb, E.; Sellick, G.; dos Santos Silva, I.; McCormack, V.; Gibson, L.; Fraser, A.; Leonard, A.; Gilham, C.; Tavtigian, S.V.; Ashworth, A.; Houlston, R.; Peto, J.;

  Hum Mol Genet, 2007; 16(9):1051-7

• Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case-control study

  Brennan, P.; McKay, J.; Moore, L.; Zaridze, D.; Mukeria, A.; Szeszenia-Dabrowska, N.; Lissowska, J.; Rudnai, P.; Fabianova, E.; Mates, D.; Bencko, V.; Foretova, L.; Janout, V.; Chow, W.H.; Rothman, N.; Chabrier, A.; Gaborieau, V.; Odefrey, F.; Southey, M.; Hashibe, M.; Hall, J.; Boffetta, P.; Peto, J.; Peto, R.; Hung, R.J.

  Human Molecular Genetics, 2007; 16(15):1794-1801

• Genome-wide association study identifies novel breast cancer susceptibility loci

  Easton, D.F.; Pooley, K.A.; Dunning, A.M.; Pharoah, P.D.P.; Thompson, D.; Ballinger, D.G.; Struewing, J.P.; Morrison, J.; Field, H.; Luben, R.; Wareham, N.; Ahmed, S.; Healey, C.S.; Bowman, R.; Meyer, K.B.; Haiman, C.A.; Kolonel, L.K.; Henderson, B.E.; le Marchand, L.; Brennan, P.; Sangrajrang, S.; Gaborieau, V.; Odefrey, F.; Shen, C.Y.; Wu, P.E.; Wang, H.C.; Eccles, D.; Evans, D.G.; Peto, J.; Fletcher, O.; Johnson, N.; Seal, S.; Stratton, M.R.; Rahman, N.; Chenevix-Trench, G.; Bojesen, S.E.; Nordestgaard, B.G.; Axelsson, C.K.; Garcia-Closas, M.; Brinton, L.; Chanock, S.; Lissowska, J.; Peplonska, B.; Nevanlinna, H.; Fagerholm, R.; Eerola, H.; Kang, D.; Yoo, K.Y.; Noh, D.Y.; Ahn, S.H.; Hunter, D.J.; Hankinson, S.E.; Cox, D.G.; Hall, P.; Wedren, S.; Liu, J.J.; Low, Y.L.; Bogdanova, N.; Schurmann, P.; Dork, T.; Tollenaar, R.; Jacobi, C.E.; Devilee, P.; Klijn, J.G.M.; Sigurdson, A.J.; Doody, M.M.; Alexander, B.H.; Zhang, J.H.; Cox, A.; Brock, I.W.; MacPherson, G.; Reed, M.W.R.; Couch, F.J.; Goode, E.L.; Olson, J.E.; Meijers-Heijboer, H.; van Den Ouweland, A.; Uitterlinden, A.; Rivadeneira, F.; Milne, R.L.; Ribas, G.; Gonzalez-Neira, A.; Benitez, J.; Hopper, J.L.; McCredie, M.; Southey, M.; Giles, G.G.; Schroen, C.; Justenhoven, C.; Brauch, H.; Hamann, U.; Ko, Y.D.; Spurdle, A.B.; Beesley, J.; Chen, X.Q.; Mannermaa, A.; Kosma, V.M.; Kataja, V.; Hartikainen, J.; Day, N.E.; Cox, D.R.; Ponder, B.A.J.

  Nature, 2007; 447(7148):1087-U7

• The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050.

  Hodgson, J.T.; McElvenny, D.M.; Darnton, A.J.; Price, M.J.; Peto, J.;

  Br J Cancer, 2005; 92(3):587-93

• Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study

  Johnson, N.; Fletcher, O.; Naceur-Lombardelli, C.; Dos Santos Silva, I. D.; Ashworth, A.; Peto, J.

  Lancet, 2005; 366(9496):1554-7

• The cervical cancer epidemic that screening has prevented in the UK.

  Peto, J.; Gilham, C.; Fletcher, O.; Matthews, F.E.;

  Lancet , 2004; 364 (9430 ):249-56

• Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort

  Peto, J.; Gilham, C.; Deacon, J.; Taylor, C.; Evans, C.; Binns, W.; Haywood, M.; Elanko, N.; Coleman, D.; Yule, R.; Desai, M.

  British Journal of Cancer, 2004; 91(5):942-53

• Cancer epidemiology in the last century and the next decade

  Peto, J.

  Nature, 2001; 411(6835):390-5

• → View all Julian Peto's publications

• Introducing Our School
• People Search
• Expert Directory
• Giving to the School
• Jobs
• Division of Education
• Academic and Administrative Services
• Governance and Organisation
• Contact Us
• Term Dates
• Policies and Regulations
• Alumni

• All Julian Peto's publications

Back to top